Join us via Zoom on Wednesday, September 25th at 6pm ET / 3pm PT for the next Clinical Update webinar in our 2024 series. Dr. Jessica Sacks, PhD, Associate Medical Director at Jazz Pharmaceuticals, will discuss XYWAV and how to ask your doctor about managing Idiopathic Hypersomnia.

Thank you to Jazz Pharmaceuticals for sponsoring this webinar:

Presented by:

Dr. Jessica Sacks, PhD is an Associate Medical Director at Jazz Pharmaceuticals, supporting Sleep and Neuroscience medical and scientific efforts in the United States. In her current role, Dr. Sacks is dedicated to advancing meaningful therapeutic discoveries that will deliver life-changing treatment options to patients with chronic sleep disorders. Prior to joining Jazz Pharmaceuticals, Dr. Sacks gained extensive clinical research experience in academic, hospital, and industry-based settings, with a focus in neurology and metabolic health. Dr. Sacks resides in San Diego, CA and received her PhD in Molecular Medicine from Case Western Reserve University and Cleveland Clinic, and her Master’s in Exercise Physiology from San Diego State University.